Understanding, avoiding, and managing dermal filler complications

被引:175
作者
Cohen, Joel L. [1 ,2 ]
机构
[1] AboutSkin Dermatol & DermSurg, Englewood, CO USA
[2] Univ Colorado, Englewood, CO USA
关键词
D O I
10.1111/j.1524-4725.2008.34249.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND Dermal fillers are increasingly being utilized for multiple cosmetic dermatology indications. The appeal of these products can be partly attributed to their strong safety profiles. Nevertheless, complications can sometimes occur. OBJECTIVE To summarize the complications associated with each available dermal filling agent, strategies to avoid them, and management options if they do arise. METHODS AND MATERIALS Complications with dermal fillers reported in peer-reviewed publications, prescribing information, and recent presentations at professional meetings were reviewed. Recommendations for avoiding and managing complications are provided, based on the literature review and the author's experience. RESULTS Inappropriate placement or superficial placement is one of the most frequent reasons for patient dissatisfaction. Due to the reversibility of hyaluronic acid, complications from these fillers can be easily corrected. Sensitivity to any of the currently approved FDA products is quite rare and can usually be managed with anti-inflammatory agents. Infection is quite uncommon as well and can usually be managed with either antibiotics or antivirals depending on the clinical features. The most concerning complication is cutaneous necrosis, and a protocol to treat the full spectrum of this process is reviewed. CONCLUSIONS Complications with dermal fillers are infrequent, and strategies to minimize their incidence and impact are easily deployed. Familiarity with each family of soft-tissue augmentation products, potential complications, and their management will optimize the use of these agents.
引用
收藏
页码:S92 / S99
页数:8
相关论文
共 21 条
[2]   NewFill for skin augmentation: A new filler or failure? [J].
Beljaards, RC ;
De Roos, KP ;
Bruins, FG .
DERMATOLOGIC SURGERY, 2005, 31 (07) :772-776
[3]   Calcium hydroxylapatite for facial rejuvenation [J].
Berlin, Alexander ;
Cohen, Joel L. ;
Goldberg, David J. .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2006, 25 (03) :132-137
[4]   Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement [J].
Brody, HJ .
DERMATOLOGIC SURGERY, 2005, 31 (08) :893-897
[5]  
*DERM LAB, 2006, SCULPTR PRESCR INF
[6]   Granulomatous foreign body reaction against hyaluronic acid:: Report of a case after lip augmentation [J].
Fernández-Aceñero, MJ ;
Zamora, E ;
Borbujo, J .
DERMATOLOGIC SURGERY, 2003, 29 (12) :1225-1226
[7]   Injection necrosis of the glabella: Protocol for prevention and treatment after use of dermal fillers [J].
Glaich, AS ;
Cohen, JL ;
Goldberg, LH .
DERMATOLOGIC SURGERY, 2006, 32 (02) :276-281
[8]   Use of Radiesse in combination with restylane for facial augmentation [J].
Godin, MS ;
Majmundar, MV ;
Chrzanowski, DS ;
Dodson, KM .
ARCHIVES OF FACIAL PLASTIC SURGERY, 2006, 8 (02) :92-97
[9]   Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase [J].
Hirsch, Ranella J. ;
Cohen, Joel L. ;
Carruthers, Jean D. A. .
DERMATOLOGIC SURGERY, 2007, 33 (03) :357-360
[10]  
Hirsch RJ, 2007, SKIN AGING, V15, P36